Laboratory Corp. (LH) Tops Q2 EPS by 3c; Reaffirms FY11 Outlook
Laboratory Corp. (NYSE: LH) reported Q2 EPS of $1.64, $0.03 better than the analyst estimate of $1.61. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.39 billion.
Reaffirms outlook.
Reaffirms outlook.